A role of Akt in prostatic cancer (PC) development is well documented (6), and here we show evidence for an epigenetically regulated cross-talk between PTEN and PHLPP in prostatic cancer cells that may preserve levels of Akt. The gene discussed is PTEN; the disease is prostate carcinoma.